Breaking News Instant updates and real-time market news.

UPLD

Upland Software

$39.85 /

-0.84 (-2.06%)

17:18
08/10/20
08/10
17:18
08/10/20
17:18

Upland Software files to sell 3.5M shares of common stock

Credit Suisse is acting as lead book-running manager for the offering.

UPLD Upland Software
$39.85 /

-0.84 (-2.06%)

08/07/20 Canaccord
Upland Software price target raised to $50 from $42 at Canaccord
08/07/20 Jefferies
Upland Software price target raised to $52 from $40 at Jefferies
05/08/20 Truist
Upland Software price target lowered to $46 from $56 at SunTrust
04/13/20 Needham
Needham cuts price targets across SaaS/Application Software names

TODAY'S FREE FLY STORIES

Recommendations
Accenture price target raised to $255 from $240 at Wedbush » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
ACN

Accenture

$233.94 /

-2.17 (-0.92%)

Wedbush analyst Moshe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

06:08 Today Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
09/21/20 Barclays
Accenture price target raised to $260 from $240 at Barclays
09/20/20 Citi
Accenture price target raised to $269 from $247 at Citi
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

Hot Stocks
Lexaria Bioscience granted DehydraTECH technology patent from USPTO » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
LXRP

Lexaria Bioscience

$0.00 /

+ (+0.00%)

Lexaria Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXRP Lexaria Bioscience
$0.00 /

+ (+0.00%)

Recommendations
Cubic strategy validated by Elliott stake, says Canaccord » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
CUB

Cubic

$59.56 /

+15.18 (+34.20%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

06:46 Today RBC Capital
Cubic price target raised to $52 from $48 at RBC Capital
09/21/20 Citi
Elliott's interest in Cubic supportive of underlying value, says Citi
09/16/20 Citi
Cubic price target raised to $60 from $50 at Citi
09/15/20 JPMorgan
Cubic price target raised to $61 from $56 at JPMorgan
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

Recommendations
Morgan Stanley says Cree poised to benefit from investments in EV, clean energy » 07:20
09/22/20
09/22
07:20
09/22/20
07:20
CREE

Cree

$58.35 /

-3.97 (-6.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$58.35 /

-3.97 (-6.37%)

09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
08/19/20 Roth Capital
Cree downgraded to Neutral from Buy at Roth Capital
08/19/20 Wells Fargo
Cree price target raised to $65 from $45 at Wells Fargo
CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

Recommendations
Illumina price target lowered to $300 from $350 at Canaccord » 07:16
09/22/20
09/22
07:16
09/22/20
07:16
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Canaccord analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

07:07 Today Baird
Illumina price target lowered to $281 from $335 at Baird
06:17 Today Citi
Illumina acquisition 'adds ambiguity' around valuation, says Citi
06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Hot Stocks
AutoZone up 5.4% to $1,250 after Q4 results beat estimates  07:14
09/22/20
09/22
07:14
09/22/20
07:14
AZO

AutoZone

$1,181.71 /

-22.41 (-1.86%)

 
ShowHide Related Items >><<
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

09/18/20 DA Davidson
AutoZone expected to outperform Q4 consensus estimates, says DA Davidson
09/17/20 Morgan Stanley
AutoZone price target raised to $1,505 from $1,140 at Morgan Stanley
09/14/20 Wells Fargo
AutoZone price target raised to $1,375 from $1,300 at Wells Fargo
09/08/20 Atlantic Equities
AutoZone upgraded to Overweight from Neutral at Atlantic Equities
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

Hot Stocks
AIM ImmunoTech announces pancreatic cancer survival results from EAP » 07:14
09/22/20
09/22
07:14
09/22/20
07:14
AIM

AIM ImmunoTech

$2.05 /

-0.03 (-1.44%)

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

04/06/20 Maxim
AIM ImmunoTech price target raised to $5 from $2 at Maxim
10/10/19 Maxim
AIM ImmunoTech has removed financing overhang, says Maxim
10/10/19 Maxim
AIM ImmunoTech upgraded to Buy from Hold at Maxim
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

Recommendations
Sykes Enterprises desiganted as a Fresh Pick at Baird » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
SYKE

Sykes Enterprises

$31.55 /

-1.5 (-4.54%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

06/04/20 Baird
Sykes Enterprises upgraded to Outperform at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform from Neutral at Baird
03/16/20 Sidoti
Sykes Enterprises upgraded to Buy from Neutral at Sidoti
11/11/19 Sidoti
Sykes Enterprises downgraded to Neutral on valuation at Sidoti
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

Hot Stocks
LiveXLive Media announces expansion in Latin America » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
LIVX

LiveXLive Media

$2.78 /

-0.23 (-7.64%)

LiveXLive Media announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

08/07/20 H.C. Wainwright
LiveXLive Media price target raised to $6 from $4.50 at H.C. Wainwright
06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

Recommendations
PPD, Inc. price target raised to $38 from $35 at Mizuho » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
PPD

PPD, Inc.

$34.14 /

+0.29 (+0.86%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
08/06/20 Mizuho
PPD, Inc. price target raised to $35 from $29 at Mizuho
08/06/20 Citi
PPD, Inc. price target raised to $37 from $31 at Citi
08/05/20 Credit Suisse
PPD, Inc. price target raised to $35 from $30 at Credit Suisse
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

  • 17
    Sep
  • 06
    Feb
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

Recommendations
Wave Life recent volatility not due to fundamentals, says Mizuho » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
WVE

Wave Life Sciences

$15.02 /

-4.6 (-23.45%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
01/02/20 H.C. Wainwright
H.C. Wainwright cuts Wave Life price target to $20, but 'not throwing in towel'
12/31/19
Fly Intel: Top five analyst actions
12/31/19 Guggenheim
Wave Huntington's data 'mediocre, but not a zero,' says Guggenheim
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

Hot Stocks
UCB: FDA, EMA accept BLA, MAA for bimekizumab » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
UCBJY

UCB

$0.00 /

+ (+0.00%)

UCB announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UCBJY UCB
$0.00 /

+ (+0.00%)

07/31/20 UBS
UCB downgraded to Neutral from Buy at UBS
07/28/20 JPMorgan
UCB price target raised to EUR 124 from EUR 114 at JPMorgan
06/15/20 Oddo BHF
UCB upgraded to Buy from Neutral at Oddo BHF
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
Earnings
CoreLogic raises FY21 revenue view to $1.97B-$2.01B from $1.91B-$1.95B » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $1.88B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

Initiation
Aldeyra initiated with a Buy at Alliance Global Partners » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
ALDX

Aldeyra

$6.97 /

-0.44 (-5.94%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

06/04/20 JonesTrading
Aldeyra pact with FDA may point to 'surer path' for approval, says JonesTrading
05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

Recommendations
Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
IONS

Ionis Pharmaceuticals

$50.24 /

-1.15 (-2.24%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
09/08/20 Citi
Ionis Pharmaceuticals price target lowered to $74 from $78 at Citi
09/02/20 Benchmark
Benchmark starts Ionis at Hold, cautious on Spinraza competition
09/02/20 Benchmark
Ionis Pharmaceuticals initiated with a Hold at Benchmark
IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

Hot Stocks
Neptune Wellness announces partnership » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
NEPT

Neptune Wellness

$2.40 /

-0.1 (-4.00%)

Neptune Wellness…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

08/27/20 Alliance Global Partners
Neptune Wellness deal shows ability to succeed in traditonal category, says AGP
08/07/20
Fly Intel: Top analyst initiations
08/07/20 Alliance Global Partners
Neptune Wellness initiated with a Buy at Alliance Global Partners
01/31/20 Cowen
Neptune Wellness initiated with a Market Perform at Cowen
NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

Hot Stocks
Medipharm Labs to supply cannabis oil to XLR8 Brazil » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Recommendations
Nike price target raised to $115 but limited upside seen, says Baird » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
NKE

Nike

$113.31 /

-1.32 (-1.15%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
09/18/20 Barclays
Nike price target raised to $132 from $118 at Barclays
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

Hot Stocks
Lowe's to install pickup lockers at all U.S. stores by end of March, 2021 » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
LOW

Lowe's

$159.61 /

-0.52 (-0.32%)

To continue to improve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

09/18/20
Fly Intel: Top five analyst downgrades
09/18/20 Oppenheimer
Oppenheimer downgrades Home Depot, Lowe's on near-term risks
09/18/20 Oppenheimer
Lowe's downgraded to Perform from Outperform at Oppenheimer
08/26/20 Jefferies
Lowe's price target raised to $205 from $193 at Jefferies
LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

LOW Lowe's
$159.61 /

-0.52 (-0.32%)

Hot Stocks
GDS Holdings announces accepted offer to acquire Beijing data center » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
GDS

GDS Holdings

$77.13 /

-1.3 (-1.66%)

GDS Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

08/25/20 Berenberg
GDS Holdings upgraded to Buy from Hold at Berenberg
08/19/20 Raymond James
GDS Holdings price target raised to $92 from $70 at Raymond James
07/27/20 HSBC
GDS Holdings initiated with a Hold at HSBC
07/20/20
Fly Intel: Top five analyst downgrades
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

  • 14
    Jan
  • 06
    Dec
GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

GDS GDS Holdings
$77.13 /

-1.3 (-1.66%)

Hot Stocks
Commercial Vehicle Group reports progress against FY20 objectives » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
CVGI

Commercial Vehicle Group

$5.24 /

-0.49 (-8.55%)

Commercial Vehicle Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

08/26/20 Barrington
Commercial Vehicle Group price target raised to $5.50 from $5 at Barrington
08/11/20 Colliers
Commercial Vehicle Group upgraded to Buy following Q2 report at Colliers
08/11/20 Colliers
Commercial Vehicle Group upgraded to Buy from Neutral at Colliers
03/18/20 Barrington
Commercial Vehicle Group price target lowered to $5 from $8.50 at Barrington
CVGI Commercial Vehicle Group
$5.24 /

-0.49 (-8.55%)

Initiation
Aptose Biosciences initiated with a Buy at Alliance Global Partners » 07:08
09/22/20
09/22
07:08
09/22/20
07:08
APTO

Aptose Biosciences

$5.88 /

-0.585 (-9.05%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/04/20 Piper Sandler
Piper Sandler likes setup for Aptose Biosciences into ASH meeting
06/12/20 Piper Sandler
Aptose Biosciences' EHA update 'incrementally positive,' says Piper Sandler
06/12/20 JonesTrading
JonesTrading optimistic about potential of Aptose Biosciences' CG-806
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

  • 16
    Jul
  • 17
    Dec
APTO Aptose Biosciences
$5.88 /

-0.585 (-9.05%)

Earnings
CoreLogic raises FY20 revenue view to $1.92B-$1.95B from $1.86B-$1.9B » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $1.97B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

Initiation
Syros Pharmaceuticals initiated with a Buy at Alliance Global Partners » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
SYRS

Syros Pharmaceuticals

$10.10 /

+0.11 (+1.10%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
08/06/20 JMP Securities
Syros Pharmaceuticals price target raised to $20 from $16 at JMP Securities
08/06/20 Piper Sandler
Syros Pharmaceuticals price target raised to $18 from $14 at Piper Sandler
05/29/20 Roth Capital
Syros Pharmaceuticals ASCO update bodes well for ph1 data, says Roth Capital
SYRS Syros Pharmaceuticals
$10.10 /

+0.11 (+1.10%)

Recommendations
Illumina price target lowered to $281 from $335 at Baird » 07:07
09/22/20
09/22
07:07
09/22/20
07:07
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

06:17 Today Citi
Illumina acquisition 'adds ambiguity' around valuation, says Citi
06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.